Precigen, Inc. (PGEN)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Precigen, Inc. (PGEN) is up 28.7% since the beginning of the year. At $5 per share, PGEN is trading just below its 52-week high of $5. Investors who bought $1,000 worth of PGEN shares 5 years ago would now be looking at an investment worth $815.

Precigen, Inc. (PGEN) has returned 28.71% so far this year and 271.03% over the past 12 months. Over the last ten years, PGEN has returned -13.73% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.

Based on dividend-adjusted daily data since Aug 8, 2013, PGEN's average daily return is +0.11%, while the average monthly return is +1.70%. At this rate, an investment would double in approximately 3.4 years.

Historically, 50% of months were positive and 50% were negative. The best month was Aug 2025 with a return of +163.7%, while the worst month was Sep 2020 at -42.2%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 8 months.

On a daily basis, PGEN closed higher 47% of trading days. The best single day was Jun 2, 2020 with a return of +83.3%, while the worst single day was Mar 1, 2019 at -36.5%.

Precigen, Inc. has an annualized alpha of 5.62%, beta of 1.65, and R2 of 0.10 versus S&P 500 Index. Calculated based on daily prices since August 08, 2013.

• This stock participated in 165.41% of S&P 500 Index downside but only 69.74% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.10 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

PGEN ranks 93 for risk / return — in the top 93% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

Precigen, Inc. provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.

The table displays the monthly dividend distributions for Precigen, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Precigen, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Precigen, Inc. was 99.00%, occurring on Dec 16, 2024. The portfolio has not yet recovered.

The current Precigen, Inc. drawdown is 92.02%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Precigen, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Precigen, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.